NCT00710502

Brief Summary

Cholecystectomy is one of the most common general surgery procedures performed in the US today and is among top 10 procedures performed in U.S. hospitals annually, and biliary tract disease has been estimated to cost U.S. healthcare $5 billion/year. Laparoscopic cholecystectomy was introduced in the early 1990s and has become the standard surgical approach for the treatment of gallbladder disease. More than 500,000 cholecystectomy procedures are performed in the US every year. Laparoscopic cholecystectomy is now performed as an outpatient basis and is related to a very low complication rate. Laparoscopic cholecystectomy requires the use of multiple trocar incisions. Natural Orifice Translumenal Endoscopic Surgery(NOTES) is a new type of surgical procedure currently being studied around the world. The idea of NOTES was developed several years ago in response to the concepts that patients would

  1. 1.realize the benefits of less invasive surgery by reducing the recovery time,
  2. 2.experience less physical discomfort associated with traditional procedures
  3. 3.have virtually no visible scarring following this type of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 4, 2008

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

December 15, 2009

Status Verified

December 1, 2009

Enrollment Period

11 months

First QC Date

July 2, 2008

Last Update Submit

December 14, 2009

Conditions

Keywords

TransvaginalNOTESCholecystectomyLaparoscopic

Outcome Measures

Primary Outcomes (1)

  • Safety and Efficacy of Transvaginal NOTES cholecystectomy when compared to Laparoscopic cholecystectomy

    12 months

Secondary Outcomes (1)

  • Short term outcomes of Transvaginal NOTES cholecystectomy when compared to Laparoscopic Cholecystectomy

    12 months

Study Arms (3)

1

EXPERIMENTAL

Transvaginal NOTES Cholecystectomy (Phase 1)

Procedure: Transvaginal NOTES cholecystectomy

2

ACTIVE COMPARATOR

Laparoscopic Cholecystectomy (Phase 2)

Procedure: Laparoscopic cholecystectomy

3

EXPERIMENTAL

Transvaginal NOTES cholecystectomy (Phase 2)

Procedure: Transvaginal NOTES cholecystectomy

Interventions

Under general anesthesia, patients will undergo Transvaginal NOTES cholecystectomy

Also known as: NOTES gallbladder removal, NOTES gallbladder surgery
13

Under general anesthesia, patients will undergo standard Laparoscopic cholecystectomy

Also known as: Small incision gallbladder surgery
2

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (\> 18 years old) female patients residents of Durango Mexico.
  • Patients who undergo elective surgery.
  • Patients with ultrasound documented symptomatic cholelithiasis, gallbladder polyps of biliary dyskinesia.
  • Patients capable of giving written informed consent for the study.

You may not qualify if:

  • Patients who have contraindications prohibiting general anesthesia.
  • Pregnancy.
  • Previous abdominal or gynecological procedures.
  • Uncontrollable medical or psychiatric conditions
  • Elderly \> 65 y/o.
  • Body Mass Index \> 35 mg/kg2.
  • Complicated or acute cholecystitis.
  • Elevation of liver function tests.
  • Acute abdomen.
  • Intra-abdominal abscess.
  • Coagulopathy.
  • Imperforated hymen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Juarez del Estado de Durango, Mexico

Durango, Durango, 34000, Mexico

Location

MeSH Terms

Conditions

Cholelithiasis

Interventions

Cholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

CholecystectomyBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, OperativeLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Officials

  • Homero Rivas, MD

    Hospital de la Paz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 2, 2008

First Posted

July 4, 2008

Study Start

January 1, 2009

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

December 15, 2009

Record last verified: 2009-12

Locations